Insider Trading News

Sight sciences CFO Alison Bauerlein sells shares price $35,579

Sight Sciences , Inc. (NASDAQ:SGHT), a medical system firm with a market capitalization of $173 million, noticed its Chief Monetary…

2 weeks ago

Sight sciences chief authorized officer sells shares price $17,131

Jeremy B. Hayden, the Chief Authorized Officer of Sight Sciences , Inc. (NASDAQ:SGHT), not too long ago bought 4,864 shares…

2 weeks ago

Sight Sciences CTO David Badawi sells $10,956 in inventory

David Badawi, Chief Know-how Officer at Sight Sciences , Inc. (NASDAQ:SGHT), not too long ago bought shares of the corporate's…

2 weeks ago

Arcellx CEO Rami Elghandour sells shares price $2.24 million

Arcellx, Inc. (NASDAQ:ACLX), a biotechnology firm with a market capitalization of $4.28 billion, just lately reported that its President, CEO,…

2 weeks ago

Endeavor group’s William Fullerton sells shares value $214,293

In a current transaction disclosed in a Securities and Change Fee submitting, William Okay. Fullerton, World Controller and Chief Accounting…

2 weeks ago

Arcellx chief medical officer sells shares price $498,795

Christopher Heery, the Chief Medical (TASE:PMCN) Officer of Arcellx, Inc. (NASDAQ:ACLX), has reported promoting shares of the corporate in a…

2 weeks ago

Arcellx’s chief medical officer sells shares value $498,795

In a latest submitting with the Securities and Trade Fee, Arcellx, Inc. (NASDAQ:ACLX), a biotech firm at the moment valued…

2 weeks ago

Arcellx CFO Michelle Gilson sells $831,378 in inventory

Arcellx, based mostly in Redwood (NYSE:RWT) Metropolis, California, is a biotechnology agency specializing in organic merchandise. The corporate's inventory is…

2 weeks ago

Arcellx CFO Michelle Gilson sells $831,378 in inventory

Arcellx, primarily based in Redwood (NYSE:RWT) Metropolis, California, is a biotechnology agency specializing in organic merchandise. The corporate's inventory is…

2 weeks ago

Soleno Therapeutics CFO James Mackaness sells $360,460 in inventory

James Mackaness, the Chief Monetary Officer of Soleno Therapeutics Inc. (NASDAQ:SLNO), an organization presently valued at $1.98 billion, just lately…

2 weeks ago